Skip to content

A randomized controlled study on the efficacy of behavioral activation therapy for anhedonia symptoms in adolescents with depression

A randomized controlled study on the efficacy of behavioral activation therapy for anhedonia symptoms in adolescents with depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109172
Enrollment
Unknown
Registered
2025-09-14
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Behavioural Activation Therapy Group:Behavioural Activation Therapy
Behavioural Activation Therapy Waiting Group:Nothing

Sponsors

Peking University Sixth Hospital ( Institute of Mental Health )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 19 Years

Inclusion criteria

Inclusion criteria: 1.Aged 12-19, male or female; 2.Meets the diagnostic criteria for depressive disorder according to DSM-5; 3.Item A2 of the MINI Kid 5.0 scale (presence of diminished interest or loss of pleasure) is assessed as "yes," and the total score on the Snaith-Hamilton Pleasure Scale (SHAPS) is >= 3 (dichotomous scoring); 4.The current medication regimen has been stable for at least 6 weeks; 5.Currently at no significant risk of suicide (MINI Kid current suicide risk score <= 17); 6.Both the patient and their guardian provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Unable to independently complete questionnaires and psychological assessments; 2.Diagnosed with significant cognitive impairment through systematic psychiatric evaluation, rendering the individual incapable of providing informed consent; 3.Received electroconvulsive therapy (ECT) or repetitive transcranial magnetic stimulation (rTMS) within the past 6 months; 4.Comorbid with other mental disorders such as neurodevelopmental disorders or autism spectrum disorder; 5.Current or history of other severe neurological and/or physical illnesses including a history of epilepsy; 6.Currently receiving other forms of psychotherapy; 7.Currently participating in other research studies; 8.Either parent is unwilling to participate in the entire intervention process.

Design outcomes

Primary

MeasureTime frame
Anhedonia symptoms;

Secondary

MeasureTime frame
Acceptability;Depressive and anxious symptoms;

Countries

China

Contacts

Public ContactSu Yunai

Peking University Sixth Hospital ( Institute of Mental Health )

suyunai@163.com+86 10 6272 3767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026